Instil Bio, Inc. (TIL) — Analyst outlook / Analyst consensus target is. Based on 7 analyst ratings, the consensus is bullish — 3 Buy, 4 Hold.
The consensus price target is $7.00, representing a downside of 17.1% from the current price $8.44.
Analysts estimate Earnings Per Share (EPS) of $-12.72 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-11.39 vs est $-12.72 (beat +10.5%). 2025: actual $-10.70 vs est $-11.53 (beat +7.2%). Analyst accuracy: 90%.
TIL Stock — 12-Month Price Forecast
$7.00
▼ -17.06% Downside
Average Price Target
Based on 7 Wall Street analysts offering 12-month price targets for Instil Bio, Inc., the price target is $7.00.
The average price target represents a -17.06% change from the last price of $8.44.
TIL Analyst Ratings
Hold
Based on 7 analysts giving stock ratings to Instil Bio, Inc. in the past 3 months
EPS Estimates — TIL
90%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$11.39
vs Est –$12.72
▲ 11.7% off
2025
Actual –$10.70
vs Est –$11.53
▲ 7.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — TIL
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
